Skip to main content
OpenTrials

Clinical trial condition

Sarcoma

Explore clinical trials studying Sarcoma. Study availability and eligibility vary by location and protocol.

1,167 public trials 263 recruiting studies
Refine in advanced search Browse all conditions

Sarcoma trial results

Recruiting

An Observational Study on Epithelioid Sarcoma

NCT03099681

Conditions
Epithelioid Sarcoma, Neoplasms, Neoplasms by Histologic Type, +2 more
Locations
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST Meldola, FC, Italy
  • Istituto Europeo di Oncologia Milan, MI, Italy
  • Istituto Clinico Humanitas Rozzano, MI, Italy
  • Azienda Ospedaliera Universitaria Paolo Giaccone Palermo, PA, Italy
View Trial Details
Recruiting

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

NCT06156410

Conditions
Disease Attributes, Ewing Sarcoma, Neoplasms, +11 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

PROMIS and Mobility Evaluation in Sarcoma Patients

NCT07227961

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Foothills Medical Centre, Arthur J Child Comprehensive Cancer Centre, University of Calgary Calgary, Alberta, Canada
  • Mount Sinai Hospital, University of Toronto Toronto, Ontario, Canada
View Trial Details
Recruiting

Pediatric Radiation Therapy Registry

NCT07129317

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +9 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Recruiting

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

NCT04370587

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +21 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions